Clinical activity of regorafenib in elderly patients with recurrent glioblastoma.
Fasano M, Pirozzi M, Famiglietti V, Facchini S, Caterino M, Caroprese M, Barillaro A, Di Giovanni I, Auriemma A, Ileana Sara Fattoruso S, Somma T, Solari D, Bocchetti M, Conson M, Pacelli R, Ciardiello F, Addeo R.
Fasano M, et al.
Mol Clin Oncol. 2023 Jan 10;18(2):9. doi: 10.3892/mco.2023.2605. eCollection 2023 Feb.
Mol Clin Oncol. 2023.
PMID: 36761386
Free PMC article.
In the present study, a real-life retrospective investigation on the role of regorafenib in patients with recurrent glioblastoma (>60 years old) from two main Oncological Units in South Italy (Azienda Ospedaliera Universitaria Luigi Vanvitelli, Naples, Italy and Ospedale Civil …
In the present study, a real-life retrospective investigation on the role of regorafenib in patients with recurrent glioblastoma (>60 yea …